Blogs



Long-term homoeoprophylaxis study in children in United States Part One: Factors contributing to the successful completion of sequential dosing of disease nosodes

Keywords: Children’s Health, Developing Immune Systems, Homoeoprophylaxis (HP), Infectious Disease, Nosodes, Public Health Program, Unvaccinated, Vaccines.

Abstract

Introduction: Currently the largest movements to curb and prevent infectious contagious disease in children are sanitary public health care measures and/or antibiotics and vaccines that carry inherent risks.[i],[ii],[iii]

Individual adherence to public health programs is variable, based on education, economic standing, and confidence in those administering the program. Homoeoprophylaxis (HP) offers a low-risk infectious contagious disease prevention method to those parents looking for alternatives.[iv],[v] 



xli.              World Health Organization (2018). Antimicrobial resistance. https://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance  (Last viewed 26 September 2019).

xlii.             Good, P (2018). Evidence the U.S. autism epidemic initiated by acetaminophen (Tylenol) is aggravated by oral antibiotic amoxicillin/clavulanate (Augmentin) and now exponentially by herbicide glyphosate (Roundup). Clinical Nutrition ESPEN. 2018 Feb;23:171-183. https://www.ncbi.nlm.nih.gov/pubmed/29460795 (Last viewed 26 September 2019).

xliii.            Taylor, G (2018). 157 Research papers supporting vaccine/autism causation. http://mainevaxchoice.org/wp-content/uploads/2018/10/VaccineAutismStudies.pdf (Last viewed 26 September 2019).

xliv.            Golden, I (2004). The potential value of homoeoprophylaxis in the long-term prevention of infectious diseases, and the maintenance of general health in recipients. Graduate School of Integrative Medicine Swinburne University of Technology. https://immunizationalternatives.com/wp-content/uploads/2015/04/HP_Isaac_Golden_thesis_homeoprophylaxis1.pdf (Last viewed 26 September 2019).

xlv.             Carmen (2012). Natural vaccine alternatives for you and your kids. Off the Grid News. https://www.offthegridnews.com/alternative-health/natural-vaccination-alternatives-for-you-and-your-kids/ (Last viewed 26 September 2019).

Continue reading

Posted in Research, Resources: Talks & Media | Leave a comment

Long-term homoeoprophylaxis study in children in North America. Part Two: Safety of HP, review of immunological responses, and effects on general health outcomes

Keywords: Adverse Events, Children’s Health, Developing Immune Systems, Healthy Immunological Response, Immunity, Homoeoprophylaxis (HP), Infectious Disease, Nosodes, Public Health Program, Unvaccinated, Vaccines, Vaccination.

Abstract

Introduction: The immunological response stimulated by infectious disease develops immunity. Childhood infectious diseases, when naturally contracted, gradually activate and mature immune systems. Both vaccination and the use of nosodes* for homoeoprophylaxis (HP)** aim to introduce infectious agents to activate disease-specific immunological responses and avoid possible risks of natural disease.[i],[ii],[iii] Both methodologies attenuate (weaken) the viral or bacterial agents to minimise the potential risk of too strong an immune system response.[iv] While vaccination comes with attended risks that sometimes are more violent than the actual disease,[v] HP offers a low-risk immunisation method as demonstrated by the production of mild, short-lived immunological responses as the desired response, and improved general health outcomes.



xli.              Birch, K (2014). Vaccines and homoeoprophylaxis share the same history. https://freeandhealthychildren.org/2014/03/16/vaccines-and-homeoprophylaxis-history/ (Last viewed 4 October 2019).

xlii.             Hahnemann, S. “The Cure and Prevention of Scarlet Fever.” Lessor Writings. B Jain Publishers, New Delhi.

xliii.            Castro, D., Nogueira, G (1968). “Use of the nosode Meningococcinum as a preventative against meningitis.” Journal of the American Institute of Homeopathy. 4 (Dec.): 211-219.

xliv.            Plitnick, L (2013). Global regulatory guidelines for vaccines. Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics. https://www.sciencedirect.com/topics/neuroscience/attenuated-vaccine (Last viewed 4 October 2019)

xlv.             Pertussis (whooping cough) disease and vaccine quick facts. National Vaccine Information Center. https://www.nvic.org/vaccines-and-diseases/whooping-cough/quick-facts.aspx (Last viewed 4 October 2019)

Continue reading

Posted in Research, Resources: Talks & Media | Leave a comment